Cai Lay Veterinary Pharmaceutical JSC (HNX:MKV)
Vietnam · Delayed Price · Currency is VND 12,800
0.00 (0.00%)
At close: Aug 12, 2026
HNX:MKV Revenue
Cai Lay Veterinary Pharmaceutical JSC had revenue of 35.40B VND in the quarter ending June 30, 2026, with 4.65% growth. This brings the company's revenue in the last twelve months to 153.97B, up 25.44% year-over-year. In the year 2025, Cai Lay Veterinary Pharmaceutical JSC had annual revenue of 149.79B with 39.94% growth.
Revenue (ttm)
153.97B
Revenue Growth
+25.44%
P/S Ratio
0.42
Revenue / Employee
1.37B
Employees
112
Market Cap
64.00B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 149.79B | 42.75B | 39.94% |
| Dec 31, 2024 | 107.04B | -3.87B | -3.49% |
| Dec 31, 2023 | 110.91B | -8.73B | -7.30% |
| Dec 31, 2022 | 119.63B | 17.22B | 16.82% |
| Dec 31, 2019 | 102.41B | -32.17B | -23.90% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Vidipha Central Pharmaceutical JSC | 979.05B |
| Ben Tre Pharmaceutical JSC | 873.41B |
| Vimedimex Medi-Pharma JSC | 812.98B |
| Pharmedic Pharmaceutical Medicinal JSC | 546.31B |
| Central Pharmaceutical Joint Stock Company No3 | 515.53B |
| Mediplantex National Pharmaceutical JSC | 291.40B |
| Lamdong Pharmaceutical JSC | 262.06B |
| SPM Corporation | 217.45B |